PHOFAY ACNE SPOT TREATMENT CREAM- salicylic acid cream

PHOFAY ACNE SPOT TREATMENT Cream by

Drug Labeling and Warnings

PHOFAY ACNE SPOT TREATMENT Cream by is a Otc medication manufactured, distributed, or labeled by Longway Technology(Guangzhou) Co., Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

SALICYLIC ACID1.08%

KEEP OUT OF REACH OF CHILDREN

lf Swallowed, Get Medica Help or Contact a Poison Control Center right away

WARNINGS

For external use only
When using this product

skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. lf irritation occurs, only use one topical acne medication at a time.

DOSAGE & ADMINISTRATION

Directions
clean the skin thoroughly before applying this product

cover the entire affected area with a thin layer one to three times daily

because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor

if bothersome dryness or peeling occurs, reduce application to once a day or every other day.

INACTIVE INGREDIENT

Water, Butylene Glycol, Caprylic/Capric Triglyceride,Cetyl Ethylhexanoate, Propylene Glycol, Dimethicone Cetearyl Alcohol, C14-22 Alcohols, Glyceryl Stearate，Niacinamide, Betaine,PEG-100 Stearate, 1,2-Hexanediol,Hydroxyacetophenone, Sodium Hydroxide, PEG-40 Hydrogenated Castor Oil, C12-20 Alkyl Glucoside,Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Xanthan Gum,Centella Asiatica Root Extract, Menthol, Dipotassium Glycyrrhizate, Citric Acid, lron Oxides (Cl 77492)

OTHER SAFETY INFORMATION

protect the product in this container from excessive

heat and direct sun

PURPOSE

Acne treatment

INDICATIONS & USAGE

For the treatment of acne
Reduces the number of acne blemishes

Helps prevent the development of new acne pimples

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

PHOFAY ACNE SPOT TREATMENT CREAM 
salicylic acid cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 85161-132
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	0.0108 g  in 1 g

Inactive Ingredients
Ingredient Name	Strength
GLYCERYL STEARATE (UNII: 230OU9XXE4)
PEG-40 HYDROGENATED CASTOR OIL (UNII: 7YC686GQ8F)
C12-20 ALKYL GLUCOSIDE (UNII: K67N5Z1RUA)
CENTELLA ASIATICA ROOT (UNII: 8MXU1P42J0)
1,2-HEXANEDIOL (UNII: TR046Y3K1G)
CETYL ETHYLHEXANOATE (UNII: 134647WMX4)
WATER (UNII: 059QF0KO0R)
DIPROPYLENE GLYCOL (UNII: E107L85C40)
PEG-100 STEARATE (UNII: YD01N1999R)
CETEARYL ALCOHOL (UNII: 2DMT128M1S)
NIACINAMIDE (UNII: 25X51I8RD4)
MENTHOL (UNII: L7T10EIP3A)
DIPOTASSIUM GLYCYRRHIZATE (UNII: CA2Y0FE3FX)
XANTHAN GUM (UNII: TTV12P4NEE)
C14-22 ALCOHOLS (UNII: B1K89384RJ)
CITRIC ACID (UNII: 2968PHW8QP)
CI 77492 (UNII: EX438O2MRT)
CAPRYLIC/CAPRIC TRIGLYCERIDE (UNII: C9H2L21V7U)
DIMETHICONE (UNII: 92RU3N3Y1O)
BETAINE (UNII: 3SCV180C9W)
HYDROXYACETOPHENONE (UNII: G1L3HT4CMH)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (60000 MPA.S) (UNII: 8Z5ZAL5H3V)

Product Characteristics
Color	yellow	Score
Shape		Size
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 85161-132-01	1 in 1 BOX	08/30/2025
1		1 g in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M006	08/30/2025

Labeler - Longway Technology(Guangzhou) Co., Ltd. (844528915)

Registrant - Longway Technology(Guangzhou) Co., Ltd. (844528915)

Establishment
Name	Address	ID/FEI	Business Operations
Longway Technology(Guangzhou) Co., Ltd.		844528915	manufacture(85161-132)